TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹43,614 Cr | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr |
What is the latest Total Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹43,614 Cr |
| Mar2025 | ₹14,396 Cr |
| Mar2024 | ₹14,505 Cr |
| Mar2023 | ₹14,468 Cr |
| Mar2022 | ₹12,606 Cr |
How is Total Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹43,614 Cr | 202.97 | |
| Mar2025 | ₹14,396 Cr | -0.76 | |
| Mar2024 | ₹14,505 Cr | 0.26 | |
| Mar2023 | ₹14,468 Cr | 14.77 | |
| Mar2022 | ₹12,606 Cr | - | |
Compare Total Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹152,396.7 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,256.0 Cr | 3% | 0.8% | 7.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.4% |
-1.5% |
39.9% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses